机构:[1]Department of Oncology,Nanhai Hospital Affiliated to Southern Medical University, Foshan, Guangdong, PR China[2]Department of Radiation Oncology,Peking University Shenzhen Hospital, Shenzhen, Guangdong, PR China北京大学深圳医院深圳市康宁医院深圳医学信息中心[3]Department of Radiation Oncology,Sichuan Cancer Hospital and Research Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China.四川省人民医院四川省肿瘤医院
Objectives There is currently no consensus on the prognostic significance of the histological subtype of nasopharyngeal carcinoma (NPC). The aim of the current study was to evaluate the impact of histological subtype on survival in NPC patients based on the Surveillance, Epidemiology, and End Results (SEER) Program. Methods Patients with NPC were identified within the SEER database (2004-2015). The effects of histological subtype on cause-specific survival (CSS) in NPC patients were evaluated using univariate and multivariate Cox regression analyses. Subgroup analysis according to histological subtype in NPC patients was carried out by 1:1 propensity score matching (PSM). Results A total of 4085 NPC patients were selected from the SEER database, including 1929 with keratinizing squamous cell carcinoma (KSCC), 2203 with nonkeratinizing carcinoma (NKC), and 53 with basaloid squamous cell carcinoma (BSCC). The 3-year and 5-year CSS rates were 61.76% and 55.07% for KSCC patients, 79.57% and 72.09% for NKC patients, and 77.55% and 74.03% for BSCC patients, respectively. Multivariate analysis identified sex, age, marital status, race, T stage, N stage, M stage, radiotherapy, chemotherapy, and histological subtype as significant prognostic factors for CSS in NPC patients. KSCC was found to be associated with worse CSS than NKC on Kaplan-Meier analysis and subgroup analysis after 1:1 PSM. Conclusions Histological subtype determines the long-term survival outcomes of patients with NPC. Moreover, the NKC subtype has the best prognosis, while the KSCC subtype has the worst prognosis. Level of Evidence NA Laryngoscope, 130:E83-E88, 2020
基金:
Medical Science Technology Project [2017AB000422]
基金编号:2017AB000422
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类|1 区医学
小类|2 区耳鼻喉科学3 区医学:研究与实验
最新[2023]版:
大类|3 区医学
小类|2 区耳鼻喉科学3 区医学:研究与实验
JCR分区:
出版当年[2020]版:
Q1OTORHINOLARYNGOLOGYQ3MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1OTORHINOLARYNGOLOGYQ3MEDICINE, RESEARCH & EXPERIMENTAL
第一作者机构:[1]Department of Oncology,Nanhai Hospital Affiliated to Southern Medical University, Foshan, Guangdong, PR China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Oncology,Nanhai Hospital Affiliated to Southern Medical University, Foshan, Guangdong, PR China[3]Department of Radiation Oncology,Sichuan Cancer Hospital and Research Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, PR China.[*1]Sichuan Cancer Hospital & Institute, No. 55 of South Renmin Road, Chengdu, Sichuan, 610041, PR China[*2]Department of Oncology, Nanhai Hospital Affiliated to Southern Medical University, No.40 Foping Road, Foshan, Guangdong, 528200, PR China
推荐引用方式(GB/T 7714):
Xing-Xi Pan,Ya-Jie Liu,Wen Yang,et al.Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients[J].LARYNGOSCOPE.2020,130(3):E83-E88.doi:10.1002/lary.28099.
APA:
Xing-Xi Pan,Ya-Jie Liu,Wen Yang,Yong-Fa Chen,Wu-Bing Tang&Chu-Rong Li.(2020).Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients.LARYNGOSCOPE,130,(3)
MLA:
Xing-Xi Pan,et al."Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients".LARYNGOSCOPE 130..3(2020):E83-E88